Vigil Neuroscience Revenue and Competitors

Boston, MA USA

Location

#4319

Growjo Ranking

Pharma

Industry

Estimated Revenue & Valuation

  • Vigil Neuroscience's estimated annual revenue is currently $7.6M per year.(i)
  • Vigil Neuroscience's estimated revenue per employee is $95,475
  • Vigil Neuroscience's total funding is $140M.

Employee Data

  • Vigil Neuroscience has 80 Employees.(i)
  • Vigil Neuroscience grew their employee count by 25% last year.

Vigil Neuroscience's People

NameTitleEmail/Phone
1
Chief Financial OfficerReveal Email/Phone
2
Chief Medical OfficerReveal Email/Phone
3
Chief Medical OfficerReveal Email/Phone
4
General CounselReveal Email/Phone
5
SVP, Clinical and Medical SciencesReveal Email/Phone
6
Head Corporate DevelopmentReveal Email/Phone
7
VP, Head NeuroimmunologyReveal Email/Phone
8
VP, Head Medical SciencesReveal Email/Phone
9
VP, Patient AdvocacyReveal Email/Phone
10
SVP, Program Leadership and Portfolio ManagemengtReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$413.3M3240%$634MN/A
#2
$47.8M2380%N/AN/A
#3
$2.4M12-52%N/AN/A
#4
$25.7M12839%N/AN/A
#5
$12.9M64129%N/AN/A
#6
$23.9M1198%$113MN/A
#7
$0.3M30%N/AN/A
#8
$10.3M51-14%N/AN/A
#9
$1.8M367-4%$538MN/A
#10
$50M2493%N/AN/A
Add Company

What Is Vigil Neuroscience?

Vigil Neuroscience is the world's first microglia-focused therapeutics company. Our purpose is clear: to treat rare and common neurodegenerative diseases by restoring the vigilance of the microglia, the sentinel cells of the brain's immune system. We are utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and their families.

keywords:N/A

$140M

Total Funding

80

Number of Employees

$7.6M

Revenue (est)

25%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Vigil Neuroscience News

2022-04-17 - VIGIL NEUROSCIENCE, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

VIGIL NEUROSCIENCE, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K).

2022-04-17 - Vigil Neuroscience Expands Leadership Team and Board of Directors

Vigil Neuroscience, Inc. - Christopher Verni appointed as General Counsel and Mary Thistle appointed to its Board of Directors -. CAMBRIDGE,...

2022-03-22 - Vigil Neuroscience Reports Fourth Quarter and Full Year 2021 ...

Vigil Neuroscience is a microglia-focused therapeutics company focused on developing treatments for both rare and common neurodegenerative...

2020-12-08 - Neurodegeneration startup launches with $50M, Amgen assets

Eight years after Atlas Venture began probing a group of nervous system cells and their effects in Alzheimer’s and other neurological disorders, the venture creation firm launched a new startup in the field this week. Vigil Neuroscience launched Tuesday with $50 million in financing from Northp ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$9.6M80-14%N/A
#2
$11.2M80-4%N/A
#3
$21.6M80-4%N/A
#4
$11.6M8021%N/A
#5
$21.6M80135%N/A